Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (507)

2024

  1. Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement (Nature Reviews Endocrinology, (2023), 19, 12, (722-740), 10.1038/s41574-023-00886-5)

    Nature Reviews Endocrinology

  2. Consensus on criteria for acromegaly diagnosis and remission

    Pituitary, Vol. 27, Núm. 1, pp. 7-22

  3. Correction: consensus on criteria for acromegaly diagnosis and remission (Pituitary, (2024), 27, 1, (7-22), 10.1007/s11102-023-01360-1)

    Pituitary

  4. Evidence-based definition of hypoprolactinemia in European men aged 40–86 years: the European male ageing study

    Reviews in Endocrine and Metabolic Disorders

  5. Hyponatremia, hypernatremia and impairment of functional, psychological and sexual domains

    Journal of Endocrinological Investigation, Vol. 47, Núm. 4, pp. 1005-1014

  6. Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold

    Aging Male, Vol. 27, Núm. 1

  7. Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)

    Pituitary, Vol. 27, Núm. 4, pp. 381-388

  8. The relationship between low prolactin and type 2 diabetes

    Reviews in Endocrine and Metabolic Disorders

2023

  1. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement

    Nature Reviews Endocrinology, Vol. 19, Núm. 12, pp. 722-740

  2. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  3. Does testosterone influence the association between sleep and frailty in men: results from the European Male Aging Study

    BMC Geriatrics, Vol. 23, Núm. 1

  4. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

    Nature Medicine, Vol. 29, Núm. 11, pp. 2885-2901

  5. Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain

    Frontiers in Endocrinology, Vol. 14

  6. Number of CAG repeats and mortality in middle aged and older men

    Clinical Endocrinology, Vol. 99, Núm. 6, pp. 559-565

  7. Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers

    Pituitary, Vol. 26, Núm. 5, pp. 583-596

2022

  1. Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21

    Nature Metabolism, Vol. 4, Núm. 7, pp. 901-917

  2. Reproductive hormone levels, androgen receptor CAG repeat length and their longitudinal relationships with decline in cognitive subdomains in men: The European Male Ageing Study.

    Physiology and Behavior, Vol. 252

2021

  1. Consensus on diagnosis and management of Cushing's disease: a guideline update

    The lancet. Diabetes & endocrinology, Vol. 9, Núm. 12, pp. 847-875

  2. International Multicenter Validation Study of the SAGIT®Instrument in Acromegaly

    Journal of Clinical Endocrinology and Metabolism, Vol. 106, Núm. 12, pp. 3555-3568

  3. Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?

    Journal of the Endocrine Society, Vol. 5, Núm. 3